THE EFFECT OF SODIUM CHLORIDE 0.9% INFUSION SOLUTION AND RINGER'S SOLUTION ON PARTICLE SIZE OF INTRAVENOUS LIPID EMULSION (INTRALIPID 20%)
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i1.15169Abstract
Objective: To study the effect of admixing intralipid (IL) with sodium chloride (NaCl) 0.9% infusion solution or Ringer's solution (RS) on physical stability of IL.
Methods: Incompatibility test was done in two methods of admixture, i.e. in one container (1:1) and through three-way stopcock (1:2). They were observed for 24 hrs on its emulsion type, pH, microscopic observation of lipid globules, and globules size.
Results: The results of admixing IL and electrolyte solution (NaCl or RS) in one container and through three-way stopcock showed no changes in color and emulsion type (O/W). Physical stability evaluation results of IL and NaCl admixture in one container and through three-way stopcock showed that the pH value was 5.1 and 5.2, respectively, and microscopic observation of lipid globules and its size showed coalescence on 24 hrs with size625.16 nm (one container) and stable during 24 hrs (three-way stopcock). Physical stability evaluation results of IL and RS admixture in one container and through three-way stopcock showed that the pH value was 4.9 and 5.1, respectively, and microscopic observation of lipid globules and its size showed coalescence on 12 hrs with size 572.81 nm (one container) and flocculation on 24 hrs with size 558.12 nm (three-way stopcock).
Conclusion: Admixing electrolyte solution (NaCl or RS) and IL in one container and through three-way stopcock causes the larger globule size of IL.
Keywords: Intralipid 20%, Sodium chloride 0.9% infusion solution, Ringer's solution, Physical stability.
Downloads
References
Bertsche T, Mayer Y, Stahl R, Hoppe-Tichy T, Encke J, Haefeli WE. Prevention of intravenous drug incompatibilities in an intensive care unit. Am J Health Syst Pharm 2008;65(19):1834-40.
Bergman HD. Incompatibilities in large volume parenterals. Drug Intell Clin Pharm 1977;11(6):345-60.
Melsungen AG. Drug Incompatibility. Germany: B. Braun; 2011. p. 8.
Konda N, Prashanth P, Arvind G, Shah S. Pharmaceutical development and compatibility studies on cytarabine injection. Asian J Pharm Clin Res 2013;6(3):142-5.
Pimple S, Maurya P, Salunke K, Singh R, Gurjar M, Shah M. Formulation development and compatibility study of dexketoprofen injection used in the management of post-operative pain. Int J Pharm Sci Rev Res 2015;30(1):299-305.
Ansel HC, Prince SJ. Kalkulasi Farmasetik. Jakarta: EGC; 2004. p. 163.
Dietitians Association of Australia. Parenteral Nutrition Manual for Adults in Health Care Facilities. Australia: Dietitians Association of Australia; 2011. p. 9-13.
Fell GL, Nandivada P, Gura KM, Puder M. Intravenous lipid emulsions in parenteral nutrition. Adv Nutr 2015;6(5):600-10.
Gargasz A. Neonatal and pediatric parenteral nutrition. AACN Adv Crit Care 2012;23(4):451-64.
Krzywda EA, Andris DA, Edmiston CE, Wallace JR. Parenteral access devices. In: ASPEN, editor. The Science and Practice of Nutrition Support. USA: American Society for Parenteral and Enteral Nutrition;
p. 257.
Mirković D, Ibrić S, Antunović M. Quality assessment of total parenteral nutrition admixtures by the use of fractional factorial design. Vojnosanit Pregl 2013;70(4):374-9.
Müller O, Krawinkel M. Malnutrition and health in developing countries. CMAJ 2005;173(3):279-86.
Riskesdas. (2010). Research Report of Basic Health. Jakarta: Health Research and Development Administration. Page 23.
WHO. Management of Severe Malnutrition: A Manual for Physicians and Other Senior Health Workers. Geneva: World Health Organization; 1999. p. 1, 7-8.
Duerksen D, McCurdy K. Essential fatty acid deficiency in a severely malnourished patient receiving parenteral nutrition. Dig Dis Sci 2005;50(12):2386-8.
Calder PC, Waitzberg DL, Koletzko B. Intravenous Lipid Emulsions. Germany: S. Karger; 2015. p. 69.
Driscoll DF, Giampietro K, Wichelhaus DP, Peterss H, Nehne J, Niemann W, et al. Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin Nutr 2001;20(2):151-7.
Cocchio C, Geib AJ, Rynn KO. Physiochemical stability of intravenous fat emulsion in combination with medications used for resuscitation. SOJ Pharm Pharm Sci 2014;1(1):1-3.
Schuh RS, Bruxel F, Teixera HF. Physicochemical properties of lecithin-based nanoemulsions obtained by spontaneous emulsification or high-pressure homogenization. Quim Nova 2014;37(7):1193-8.
Filomeno LT, Carelli CR, Da Silvia NC, De Barros Filho TE, Amatuzzi MM. Fat embolism: A review for current orthopaedics practice. Acta Ortop Bras 2005;13(4):196-208.
Brust M, Schaefer C, Doerr R, Pan L, Garcia M, Arratia PE, et al. Rheology of human blood plasma: Viscoelastic versus newtonian behavior. American Physical Society 2013;110(7):1-5.
Mestres GM, Nielloud F. Emulsions in health care applications—An overview. J Dispers Sci Technol 2002;23(1-3):419-39.
Vaessen GE, Vissachers M, Stein HN. Predicting catastrophic phase inversion on the basis of droplet coalescence kinetics. Am Chem Soc 1996;12(4):875-82.
Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients. 6th ed. USA: Pharmaceutical Press; 2009. p. 385, 499, 501.
Floyd AG. Top ten considerations in the development of parenteral emulsions. PSTT 1999;2(4):134-43.
Zhao N, Liu X, Sun Y, Wang Y, Pu X, Qin Y, et al. Factors affecting particle size of an intravenous fat emulsions. Asian J Pharm Sci 2010;5(4):161-7.
USP. The United States Pharmacopeia. 36rd ed. USA: The United States Pharmacopeial Convention; 2012. p. 321-3, 4124-5.
Zhao N, Qin Y, Sun Y, Sun J, He Z. Formulation and preparation of a nitrendipine submicron emulsion. Asian J Pharm Sci 2011;6(3-4):151-8.
WiÄ…cek AE. Effect of phospholipid and (phospho) lipase modification on interfacial properties of oil/water emulsion. UMCS Chem 2015;52(1):79-109.
Martin AN. Martin’s Physical Pharmacy and Pharmaceutical Sciences. China: Lippincott Williams & Wilkins; 2011. p. 420-7.
Wermuth CG, Aldous D, Raboisson P, Rognan D. The Practice of Medicinal Chemistry. 4th ed. USA: Elsevier; 2015. p. 716.
Schroder AM. Total parenteral nutrition - Problems in compatibility and stability. EJHP Pract 2008;14(1):65-7.
Baker MT, Naguib M. Propofol: The challenges of formulation. Anesthesiology 2005;103(4):860-76.
Burgess DJ. Injectable Dispersed Systems. USA: Taylor & Francis Group; 2005. p. 101, 213, 223, 218-9.
Sacks GS. Drug-nutrient considerations in patients receiving parenteral and enteral nutrition. Pract Gastroenterol 2004;19:39-48.
Barret KE, Barman SM, Boitano S, Brooks HL. Ganong’s Review of Medical Physiology. 23rd ed. USA: The McGraw-Hill Companies, Inc.; 2010. p. 2.
Wermuth CG, Aldous D, Raboisson P, Rognan D. The Practice of Medicinal Chemistry. 4th ed. USA: Elsevier; 2015. p. 716.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
